Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer - Authors' reply

  • 0Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA.

|

|

Summary

No abstract available on PubMed